| HOME | ABOUT ACCESS TO INSIGHT |
ABOUT NOVO NORDISK |
CORE FACULTY & REVIEW BOARD |
BASIC RESEARCH GRANT |
CLINICAL RESEARCH GRANT | RECIPIENTS | CONTACT US |
The Access to Insight Grants Core Faculty is pleased to announce Access to Insight – the Novo Nordisk Haemostasis Grants Initiative, which offers exciting funding opportunities specially tailored to the needs of talented haemostasis physicians and researchers.
Novo Nordisk, a healthcare company with a leading position in haemostasis management, is strongly committed to
supporting haemostasis research and education.
The initiative is steered by the Access to Insight Grants Core Faculty, a group of distinguished haemostasis experts chaired by
Nigel Key, MB ChB, FRCP, from the University of North Carolina School of Medicine and the Harold R. Roberts Comprehensive Hemophilia
Diagnostic and Treatment Center in Chapel Hill, NC, USA.
- up to € 70,000
- 12–18 month period
- Focus: Basic science or translational
research relevant to the under-
standing of the pathophysiology
and treatment of haemostatic
disorders
- up to € 70,000
- 12 month period
- Focus: Innovative haemostatic
research on patient outcomes,
quality of life, and social impacts
SERVICES
The Haemophilia Academy
is an independently run
training programme led
by a distinguished faculty
of haemophilia experts.
